Tel-aviv Sourasky Medical Center

This study tests a drug called mosunetuzumab, given as a shot under the skin, for people with a slow-growing type of blood cancer (follicular lymphoma) that has a low amount of tumor and has not been treated before. The goal is to see how well the drug shrinks tumors and to check…

This early-stage study tests whether adding an experimental drug called CLS-015 to standard CAR-T cell therapy can improve outcomes for people with large B-cell lymphoma that has stopped responding or is progressing. The drug aims to reverse harmful effects of immune cells called…